Tuo J Y, Zhang M, Zheng R S, Zhang S W, Li G C, Yang N N, Chen W Q
Hubei Cancer Hospital/Hubei Cancer Registry Center, Wuhan 430079, China.
National Office for Cancer Prevention and Control, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaM.
Zhonghua Zhong Liu Za Zhi. 2018 Dec 23;40(12):894-899. doi: 10.3760/cma.j.issn.0253-3766.2018.12.004.
The incidence and mortality of gallbladder cancer from Chinese cancer registries in 2014 were analyzed to describe the prevalence of gallbladder cancer in China. Incidence and mortality data of gallbladder cancer in 2014 derived from registration data in 2017, collected by the National Central Cancer Registry (NCCR). Qualified data from 339 cancer registries were calculated after evaluating. According to the national population data of 2014, the gallbladder cancer incidence and mortality of China in 2014 were stratified by the area, gender and age.The age composition of standard population of Chinese census in 2000 and Segi's population were used for age-standardizes incidence and mortality in China and worldwide. 339 cancer registries cover a total of 288 243 347 population including 146 203 891 males and 142 039 456 females (144 061 915 in urban and 144 181 432 in rural areas). The mortality to incidence ratio of gallbladder cancer was 0.74. The morphologically verified cases (MV%) and death certificate-only cases (DCO%) were 48.38% and 2.66%, respectively. Unclear diagnosis cases (UB%) was 0.48%. The crude incidence of gallbladder cancer in China in 2014 was 3.82/100 000, which accounted for 1.37% of new cancer cases (4.48/100 000 in urban areas and 3.01/100 000 in rural areas, 3.59/100 000 for male and 4.05/100 000 for female). Age-standardized incidence rates by Chinese standard population (ASR China) and world standard population (ASR world) were 2.38/100 000 and 2.37/100 000, respectively, and the cumulative incidence rate (0-74 age years old) was 0.27%.Besides, the crude mortality of gallbladder cancer was 2.86/100 000 (3.47/100 000 in urban areas and 2.12/100 000 in rural areas, 2.59/100 000 for male and 3.14/100 000 for female). Age-standardized mortality rates by ASR China and ASR world were 1.72/100 000 and 1.71/100 000, with a cumulative mortality rate (0-74 age years old) of 0.19%. The incidence and mortality of gallbladder cancer were significantly different between the city and country, while not obviously different between the female and male.
分析了2014年中国癌症登记处的胆囊癌发病率和死亡率,以描述中国胆囊癌的流行情况。2014年胆囊癌的发病率和死亡率数据来自国家癌症中心(NCCR)2017年收集的登记数据。在评估后计算了339个癌症登记处的合格数据。根据2014年的全国人口数据,按地区、性别和年龄对2014年中国的胆囊癌发病率和死亡率进行了分层。使用2000年中国人口普查标准人口的年龄构成和世标人口对中国和全球的发病率和死亡率进行年龄标准化。339个癌症登记处覆盖总人口288243347人,其中男性146203891人,女性142039456人(城市144061915人,农村144181432人)。胆囊癌的死亡率与发病率之比为0.74。形态学确诊病例(MV%)和仅依据死亡证明的病例(DCO%)分别为48.38%和2.66%。诊断不明病例(UB%)为0.48%。2014年中国胆囊癌的粗发病率为3.82/10万,占新发癌症病例的1.37%(城市地区为4.48/10万,农村地区为3.01/10万,男性为3.59/10万,女性为4.05/10万)。按中国标准人口(ASR China)和世界标准人口(ASR world)计算的年龄标准化发病率分别为2.38/10万和2.37/10万,累积发病率(0至74岁)为0.27%。此外,胆囊癌的粗死亡率为2.86/10万(城市地区为